IDXG - Interpace Biosciences, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2020)Next Qtr. (Sep 2020)Current Year (2020)Next Year (2021)
No. of Analysts4444
Avg. Estimate-1.48-0.97-5.1-2.13
Low Estimate-1.72-1.24-6.18-3.26
High Estimate-1.02-0.74-3.73-1.35
Year Ago EPS-1.4-1.9-7.25-5.1
Revenue EstimateCurrent Qtr. (Jun 2020)Next Qtr. (Sep 2020)Current Year (2020)Next Year (2021)
No. of Analysts4444
Avg. Estimate5.87M8.5M33.76M48.93M
Low Estimate5.77M6.72M30.45M42.29M
High Estimate6.1M10.4M37.3M53.4M
Year Ago Sales6.27M7.72M24.08M33.76M
Sales Growth (year/est)-6.40%10.00%40.20%44.90%
Earnings History6/29/20199/29/201912/30/20193/30/2020
EPS Est.-0.58-1.92-0.74-1.24
EPS Actual-1.4-1.9-2.95-2.32
Difference-0.820.02-2.21-1.08
Surprise %-141.40%1.00%-298.60%-87.10%
EPS TrendCurrent Qtr. (Jun 2020)Next Qtr. (Sep 2020)Current Year (2020)Next Year (2021)
Current Estimate-1.48-0.97-5.1-2.13
7 Days Ago-1.48-0.97-5.1-1.75
30 Days Ago-1.38-1.07-4.57-1.14
60 Days Ago-1.38-1.07-4.57-1.14
90 Days Ago-0.46-0.37-1.590.37
EPS RevisionsCurrent Qtr. (Jun 2020)Next Qtr. (Sep 2020)Current Year (2020)Next Year (2021)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 Days121N/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesIDXGIndustrySector(s)S&P 500
Current Qtr.-5.70%N/AN/AN/A
Next Qtr.48.90%N/AN/AN/A
Current Year29.70%N/AN/AN/A
Next Year58.20%N/AN/AN/A
Next 5 Years (per annum)15.00%N/AN/AN/A
Past 5 Years (per annum)-23.06%N/AN/AN/A